View Single Post
Old 08-15-2017, 07:36 AM
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by johnt View Post
Although behind a pay wall, I came across a paper [1] which shows correlations between various PD measures. MDS-UPDRS Part III scores and PDQ-8 [2], a PD quality of life questionnaire, have a correlation of 0.47. If you take the square of the correlation, you get the proportion of the variance that can be attributed to a factor. Here we have 0.47 x 0.47 = 0.22. So, less than a quarter of the variance is explained by the Part III score. In fact the situation is probably worse than that: the PDQ-8 is itself a proxy measure of the true progression of the disease.

Reference:

[1] Eur J Neurol. 2014 Mar;21(3):519-24. doi: 10.1111/ene.12349. Epub 2014 Jan 21.
"Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients."
Martínez-Martín P1, Rodríguez-Blázquez C, Forjaz MJ, Alvarez-Sánchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martínez-Castrillo JC, Mendoza-Rodríguez A, Moore HP, Rodríguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG.
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. - PubMed - NCBI

[2] Parkinson’s Disease Questionnaire

John

John, I have a copy of this article (and some others) that I can email to you when I get a chance (I'm traveling this week). It's a great point that you make and I fully agree. I think most PD researchers are aware of the limitation of the UPDRS. The need for better biomarker measurements is very evident
Tupelo3 is offline   Reply With QuoteReply With Quote